Premium
Lack of protection from development of multiple melanomas by an injected melanocortin analogue in a combined high‐risk MC1R / CDKN2A genotype patient
Author(s) -
Böhm M.,
Jagirdar K.,
Sturm R.A.,
König S.,
Bauer J.,
Metze D.,
Luger T.A.,
Weishaupt C.
Publication year - 2016
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.13310
Subject(s) - medicine , cdkn2a , genotype , melanocortin 1 receptor , melanocortin , cancer , gene , genetics , allele , receptor , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom